Crewe Advisors LLC Has $115,000 Stake in Colgate-Palmolive (NYSE:CL)

Crewe Advisors LLC decreased its holdings in Colgate-Palmolive (NYSE:CLFree Report) by 44.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,261 shares of the company’s stock after selling 994 shares during the quarter. Crewe Advisors LLC’s holdings in Colgate-Palmolive were worth $115,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Union Bancaire Privee UBP SA acquired a new stake in Colgate-Palmolive in the 4th quarter worth about $32,000. Hager Investment Management Services LLC acquired a new stake in Colgate-Palmolive in the 4th quarter worth about $36,000. Reston Wealth Management LLC acquired a new stake in Colgate-Palmolive in the 3rd quarter worth about $42,000. Synergy Asset Management LLC acquired a new stake in Colgate-Palmolive in the 4th quarter worth about $49,000. Finally, Capital Performance Advisors LLP acquired a new position in shares of Colgate-Palmolive in the 3rd quarter valued at approximately $53,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.2 %

CL opened at $86.66 on Thursday. The company’s 50 day moving average price is $90.98 and its two-hundred day moving average price is $96.99. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26. Colgate-Palmolive has a fifty-two week low of $82.68 and a fifty-two week high of $109.30. The firm has a market capitalization of $70.80 billion, a price-to-earnings ratio of 24.62, a PEG ratio of 3.61 and a beta of 0.44.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the firm earned $0.87 earnings per share. As a group, research analysts predict that Colgate-Palmolive will post 3.74 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.31%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the stock. TD Cowen dropped their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. UBS Group dropped their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research report on Monday. Stifel Nicolaus dropped their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday. Raymond James restated an “outperform” rating and issued a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday. Finally, Morgan Stanley dropped their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $101.16.

View Our Latest Stock Report on Colgate-Palmolive

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.